Chorda Pharma addresses the growing incidence of arthritis, diabetic neuropathy, sports injuries, and other ailments.
Chorda Pharma has raised $293K in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Chorda Pharma is headquartered in Roanoke, United States.
Chorda Pharma addresses the growing incidence of arthritis, diabetic neuropathy, sports injuries, and other ailments.
Chorda Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chorda Pharma — Funding & Investors." VCBacked, April 26, 2022, https://www.vcbacked.co/company/chorda-pharma. Accessed August 14, 2026.
VCBacked. (2022). Chorda Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/chorda-pharma
{{cite web |title=Chorda Pharma — Funding & Investors |url=https://www.vcbacked.co/company/chorda-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated